Literature DB >> 666297

Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella.

E J Perea, M A Torres, M V Borobio.   

Abstract

Ninety strains of Salmonella and 50 strains of Shigella were tested for susceptibility to fosfomycin, chloramphenicol, and ampicillin by the agar dilution method. Drug interaction between fosfomycin-ampicillin and fosfomycin-chloramphenicol was studied by the agar dilution method. The fractional inhibitory concentration was calculated. The combination of fosfomycin-ampicillin was synergistic against Salmonella in 74 cases, additive in 7, indifferent in 7, antagonistic in none, and nonevaluable in 2; against Shigella it was synergistic in 27 cases, additive in 9, indifferent in 14, and antagonistic in none. The combination of fosfomycin-chloramphenicol was synergistic against Salmonella in 56 cases, additive in 9, indifferent in 13, nonevaluable in 12, and antagonistic in none; against Shigella it was synergistic in 29 cases, additive in 10, indifferent in 9, nonevaluable in 2, and antagonistic in none. Killing curves with combinations of each antimicrobial agent showed that the cultures that had proven to be indifferent by the agar dilution method showed a bactericidal effect until h 4, with posterior regrowth of the culture after this time period. For the strains in which synergism was demonstrated, total bactericidal activity was reached at 24 h.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666297      PMCID: PMC352320          DOI: 10.1128/AAC.13.5.705

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  GENTAMICIN AND AMPICILLIN: SYNERGISM WITH OTHER ANTIBIOTICS.

Authors:  R J BULGER; W M KIRBY
Journal:  Am J Med Sci       Date:  1963-12       Impact factor: 2.378

2.  Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.

Authors:  G B ELION; S SINGER; G H HITCHINGS
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

3.  Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis.

Authors:  I Phillips; C Warren
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  Phosphonomycin (MK-955). Quantitative sensitivity spectra of various hospital strains to this new antibiotic.

Authors:  M Moreno-López; D Dámaso; E J Perea; A S Sousa; L Martínez; L Marco
Journal:  Microbiol Esp       Date:  1971 Apr-Jun

5.  Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.

Authors:  J E Rosenblatt; P R Stewart
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

6.  [Combination of bacteriostatic and bactericidal drugs: lack of significant in vitro antagonism between penicillin, cephalothin, and rolitetracycline].

Authors:  F D Daschner
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

7.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

8.  Synergism of carbenicillin and gentamicin against enterococci.

Authors:  R D Libke; C Regamey; J T Clarke; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

  8 in total
  6 in total

1.  Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

Authors:  P M Miniter; T F Patterson; M A Johnson; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

2.  Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.

Authors:  Antonia C Kastoris; Petros I Rafailidis; Evridiki K Vouloumanou; Ioannis D Gkegkes; Matthew E Falagas
Journal:  Eur J Clin Pharmacol       Date:  2010-02-26       Impact factor: 2.953

3.  Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species.

Authors:  A Goer; L S Blanchard; A Van Belkum; K J Loftus; T P Armstrong; S G Gatermann; D Shortridge; B J Olson; J K Meece; T R Fritsche; M Pompilio; D Halimi; C Franceschi
Journal:  J Clin Microbiol       Date:  2022-06-23       Impact factor: 11.677

4.  Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.

Authors:  H C Neu; T Kamimura
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

5.  Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment.

Authors:  Reza Ranjbar; Abbas Farahani
Journal:  Infect Drug Resist       Date:  2019-10-07       Impact factor: 4.003

6.  Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.

Authors:  J T Downs; V T Andriole; J L Ryan
Journal:  Yale J Biol Med       Date:  1986 Jan-Feb
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.